FDA has approved Jelmyto (mitomycin gel), the first therapy to treat low-grade upper tract urothelial cancer (UTUC). Urothelial cancer is a cancer of the lining of the urinary system.
Read more: FDA Approves First Therapy for Treatment of Low-Grade Upper Tract Urothelial Cancer